Drug Profile
SYN 454
Latest Information Update: 15 Mar 2007
Price :
$50
*
At a glance
- Originator Taiho Pharmaceutical
- Class Antibacterials; Cephems
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 25 May 1995 No-Development-Reported for Bacterial infections in Canada (Unknown route)